Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6825525 | Schizophrenia Research | 2014 | 8 Pages |
Abstract
Although there was no significant association between BDNF Val66Met polymorphism and TD or AIMS scores across all patients, our results suggest that BDNF Val66Met polymorphism affects severity and, possibly, TD development in Caucasians. Since the number of studies and patients was still small, additional data are needed to confirm genotype-racial interactions. Furthermore, BDNF enhancing treatments for TD may require further study, especially in Caucasians.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Itaru Miura, Jian-Ping Zhang, Masahiro Nitta, Todd Lencz, John M. Kane, Anil K. Malhotra, Hirooki Yabe, Christoph U. Correll,